Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 427

1.

PLK1 expression and BI 2536 effects in childhood acute lymphoblastic leukemia.

Oliveira JC, Pezuk JA, Brassesco MS, Morales AG, Queiroz RG, Scrideli CA, Tone LG.

Pediatr Blood Cancer. 2014 Jul;61(7):1227-31. doi: 10.1002/pbc.24978. Epub 2014 Feb 12.

PMID:
24519995
[PubMed - indexed for MEDLINE]
2.

In vitro targeting of Polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors.

Brassesco MS, Pezuk JA, Morales AG, de Oliveira JC, Roberto GM, da Silva GN, Francisco de Oliveira H, Scrideli CA, Tone LG.

Cancer Biol Ther. 2013 Jul;14(7):648-57. doi: 10.4161/cbt.25087. Epub 2013 May 31.

PMID:
23792639
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation.

Tandle AT, Kramp T, Kil WJ, Halthore A, Gehlhaus K, Shankavaram U, Tofilon PJ, Caplen NJ, Camphausen K.

Eur J Cancer. 2013 Sep;49(14):3020-8. doi: 10.1016/j.ejca.2013.05.013. Epub 2013 Jun 18.

PMID:
23790466
[PubMed - indexed for MEDLINE]
4.

PLK1 signaling in breast cancer cells cooperates with estrogen receptor-dependent gene transcription.

Wierer M, Verde G, Pisano P, Molina H, Font-Mateu J, Di Croce L, Beato M.

Cell Rep. 2013 Jun 27;3(6):2021-32. doi: 10.1016/j.celrep.2013.05.024. Epub 2013 Jun 13.

PMID:
23770244
[PubMed - indexed for MEDLINE]
Free Article
5.

Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation.

Pezuk JA, Brassesco MS, Morales AG, de Oliveira JC, de Oliveira HF, Scrideli CA, Tone LG.

Cancer Biother Radiopharm. 2013 Sep;28(7):516-22. doi: 10.1089/cbr.2012.1415. Epub 2013 May 28.

PMID:
23713868
[PubMed - indexed for MEDLINE]
6.

The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia.

Casolaro A, Golay J, Albanese C, Ceruti R, Patton V, Cribioli S, Pezzoni A, Losa M, Texido G, Giussani U, Marchesi F, Amboldi N, Valsasina B, Bungaro S, Cazzaniga G, Rambaldi A, Introna M, Pesenti E, Alzani R.

PLoS One. 2013;8(3):e58424. doi: 10.1371/journal.pone.0058424. Epub 2013 Mar 8.

PMID:
23520509
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.

Zhang G, Zhang Z, Liu Z.

Tumour Biol. 2013 Jun;34(3):1887-94. doi: 10.1007/s13277-013-0732-0. Epub 2013 Mar 14.

PMID:
23494182
[PubMed - indexed for MEDLINE]
8.

Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer.

Maire V, Némati F, Richardson M, Vincent-Salomon A, Tesson B, Rigaill G, Gravier E, Marty-Prouvost B, De Koning L, Lang G, Gentien D, Dumont A, Barillot E, Marangoni E, Decaudin D, Roman-Roman S, Pierré A, Cruzalegui F, Depil S, Tucker GC, Dubois T.

Cancer Res. 2013 Jan 15;73(2):813-23. doi: 10.1158/0008-5472.CAN-12-2633. Epub 2012 Nov 9.

PMID:
23144294
[PubMed - indexed for MEDLINE]
Free Article
9.

High mitotic activity of Polo-like kinase 1 is required for chromosome segregation and genomic integrity in human epithelial cells.

Lera RF, Burkard ME.

J Biol Chem. 2012 Dec 14;287(51):42812-25. doi: 10.1074/jbc.M112.412544. Epub 2012 Oct 27.

PMID:
23105120
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

[Effect of Plk1 330/597 serine phosphorylated mutant on cytokinesis during mitosis].

Cheng L, Chen LJ, An R, Du J.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Oct;28(10):1016-9. Chinese.

PMID:
23046929
[PubMed - indexed for MEDLINE]
11.

Polo-like kinase-1 regulates kinetochore-microtubule dynamics and spindle checkpoint silencing.

Liu D, Davydenko O, Lampson MA.

J Cell Biol. 2012 Aug 20;198(4):491-9. doi: 10.1083/jcb.201205090.

PMID:
22908307
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells.

Zhang C, Sun X, Ren Y, Lou Y, Zhou J, Liu M, Li D.

Cancer Biol Ther. 2012 Oct;13(12):1214-20. doi: 10.4161/cbt.21412. Epub 2012 Aug 15.

PMID:
22892842
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis.

Deeraksa A, Pan J, Sha Y, Liu XD, Eissa NT, Lin SH, Yu-Lee LY.

Oncogene. 2013 Jun 13;32(24):2973-83. doi: 10.1038/onc.2012.309. Epub 2012 Aug 13.

PMID:
22890325
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

[Screening and identification of Polo-like kinase 1 as a 14-3-3Zeta-interacting protein].

Du J, Cheng L, Chen LJ, Chen Y, An R.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Aug;28(8):804-7. Chinese.

PMID:
22863584
[PubMed - indexed for MEDLINE]
15.

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma.

Mok WC, Wasser S, Tan T, Lim SG.

World J Gastroenterol. 2012 Jul 21;18(27):3527-36. doi: 10.3748/wjg.v18.i27.3527.

PMID:
22826617
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells.

Francescangeli F, Patrizii M, Signore M, Federici G, Di Franco S, Pagliuca A, Baiocchi M, Biffoni M, Ricci Vitiani L, Todaro M, De Maria R, Zeuner A.

Stem Cells. 2012 Sep;30(9):1819-30. doi: 10.1002/stem.1163.

PMID:
22753241
[PubMed - indexed for MEDLINE]
Free Article
17.

Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells.

Han DP, Zhu QL, Cui JT, Wang PX, Qu S, Cao QF, Zong YP, Feng B, Zheng MH, Lu AG.

Med Sci Monit. 2012 Jun;18(6):BR237-46.

PMID:
22648245
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

A stringent requirement for Plk1 T210 phosphorylation during K-fiber assembly and chromosome congression.

Paschal CR, Maciejowski J, Jallepalli PV.

Chromosoma. 2012 Dec;121(6):565-72. doi: 10.1007/s00412-012-0375-8. Epub 2012 May 9.

PMID:
22566210
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells.

Harris PS, Venkataraman S, Alimova I, Birks DK, Donson AM, Knipstein J, Dubuc A, Taylor MD, Handler MH, Foreman NK, Vibhakar R.

BMC Cancer. 2012 Mar 5;12:80. doi: 10.1186/1471-2407-12-80.

PMID:
22390279
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk